PD-0899 Report dose-to-medium in clinical trials; a consensus from the Global Harmonisation Group. (August 2021) - Kry, S.; Lye, J.; Clark, C.; Andratschke, N.; Dimitriadis, A.; Followill, D.; Howell, R.; Hussein, M.; Ishikawa, M.; Kito, S.; Kron, T.; Lee, J.; et al.